Renaissance Technologies’s ICU Medical ICUI Stock Holding History

Renaissance Technologies’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Sell	11,309 -24,991	-69%	-$3.59M	﹤0.01%	2062
2025 Q4	$5.18M	Sell	36,300 -33,100	-48%	-$4.43M	0.01%	1286
2025 Q3	$8.33M	Sell	69,400 -17,200	-20%	-$2.18M	0.01%	1190
2025 Q2	$11.4M	Buy	86,600 +77,800	+884%	+$10.5M	0.02%	988
2025 Q1	$1.22M	Buy	+8,800	New	+$1.37M	﹤0.01%	2281
2024 Q3	–	Sell	-10,000	Closed	-$1.19M	–	3688
2024 Q2	$1.19M	Buy	+10,000	New	+$1.05M	﹤0.01%	2225
2023 Q3	–	Sell	-86,000	Closed	-$15.3M	–	3865
2023 Q2	$15.3M	Buy	86,000 +58,600	+214%	+$10.8M	0.02%	802
2023 Q1	$4.52M	Buy	27,400 +18,800	+219%	+$3.23M	0.01%	1529
2022 Q4	$1.35M	Sell	8,600 -38,600	-82%	-$5.87M	﹤0.01%	2334
2022 Q3	$7.11M	Sell	47,200 -35,300	-43%	-$5.87M	0.01%	1220
2022 Q2	$13.6M	Buy	82,500 +17,900	+28%	+$3.45M	0.02%	943
2022 Q1	$14.4M	Sell	64,600 -10,400	-14%	-$2.33M	0.02%	927
2021 Q4	$17.8M	Sell	75,000 -17,400	-19%	-$4.06M	0.02%	772
2021 Q3	$21.6M	Buy	92,400 +37,100	+67%	+$7.78M	0.03%	644
2021 Q2	$11.4M	Buy	55,300 +23,300	+73%	+$4.79M	0.01%	1090
2021 Q1	$6.57M	Buy	32,000 +13,200	+70%	+$2.79M	0.01%	1483
2020 Q4	$4.03M	Sell	18,800 -25,000	-57%	-$4.85M	﹤0.01%	1724
2020 Q3	$8.01M	Buy	43,800 +31,000	+242%	+$5.84M	0.01%	1289
2020 Q2	$2.36M	Buy	12,800 +10,400	+433%	+$2.07M	﹤0.01%	2105
2020 Q1	$484K	Buy	+2,400	New	+$462K	﹤0.01%	2771
2019 Q3	–	Sell	-9,100	Closed	-$2.29M	–	3544
2019 Q2	$2.29M	Buy	+9,100	New	+$2.11M	﹤0.01%	2256
2019 Q1	–	Sell	-76,300	Closed	-$17.5M	–	3551
2018 Q4	$17.5M	Sell	76,300 -132,789	-64%	-$32.7M	0.02%	966
2018 Q3	$59.1M	Sell	209,089 -103,411	-33%	-$30.3M	0.06%	381
2018 Q2	$91.8M	Buy	312,500 +3,400	+1%	+$929K	0.1%	228
2018 Q1	$78M	Sell	309,100 -23,600	-7%	-$5.55M	0.09%	276
2017 Q4	$71.9M	Sell	332,700 -110,300	-25%	-$22.3M	0.08%	298
2017 Q3	$82.3M	Sell	443,000 -145,300	-25%	-$25.3M	0.1%	235
2017 Q2	$101M	Sell	588,300 -108,549	-16%	-$17.4M	0.13%	169
2017 Q1	$106M	Sell	696,849 -42,851	-6%	-$6.26M	0.15%	136
2016 Q4	$109M	Buy	739,700 +700	+0.1%	+$101K	0.17%	106
2016 Q3	$93.4M	Sell	739,000 -54,100	-7%	-$6.52M	0.17%	111
2016 Q2	$89.4M	Sell	793,100 -48,900	-6%	-$5.08M	0.17%	94
2016 Q1	$87.7M	Buy	842,000 +29,200	+4%	+$2.79M	0.17%	103
2015 Q4	$91.7M	Buy	812,800 +50,200	+7%	+$5.55M	0.2%	76
2015 Q3	$83.5M	Buy	762,600 +73,866	+11%	+$7.9M	0.2%	75
2015 Q2	$65.9M	Buy	688,734 +79,034	+13%	+$7.39M	0.15%	124
2015 Q1	$56.8M	Buy	609,700 +64,959	+12%	+$5.68M	0.12%	177
2014 Q4	$44.6M	Sell	544,741 -13,159	-2%	-$1.01M	0.11%	204
2014 Q3	$35.8M	Sell	557,900 -87,600	-14%	-$5.37M	0.1%	235
2014 Q2	$39.3M	Sell	645,500 -86,701	-12%	-$5.12M	0.09%	243
2014 Q1	$43.8M	Buy	732,201 +133,701	+22%	+$8.24M	0.11%	210
2013 Q4	$38.1M	Buy	598,500 +203,900	+52%	+$13.1M	0.09%	249
2013 Q3	$26.8M	Buy	394,600 +141,000	+56%	+$10.1M	0.07%	368
2013 Q2	$18.3M	Buy	+253,600	New	+$16.8M	0.05%	485

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's ICUI Position: Q1 2026 in Review

Renaissance Technologies reduced its ICU Medical (ICUI) stake by 69% in Q1 2026, selling an estimated $3.59M and leaving 11,309 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Renaissance Technologies first reported a position in ICUI in Q2 2013 and has held it in 44 quarters since. The position peaked at $109M in Q4 2016. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

Renaissance Technologies held 11,309 shares of ICU Medical worth $1.46M as of Q1 2026.
Renaissance Technologies sold 24,991 ICU Medical shares in Q1 2026, an estimated $3.59M.
ICU Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2062 holding.
Renaissance Technologies first reported a position in ICU Medical in Q2 2013 and has held it in 44 quarters since.
Renaissance Technologies's ICU Medical position peaked at $109M in Q4 2016.
275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.